Cargando…

Effect of prior cancer on survival outcomes for patients with advanced prostate cancer

BACKGROUND: A history of prior cancer commonly results in exclusion from cancer clinical trials. However, whether a prior cancer history has an adversely impact on clinical outcomes for patients with advanced prostate cancer (APC) remains largely unknown. We therefore aimed to investigate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yechen, Chen, Xi, Qian, Duocheng, Wang, Wei, Zhang, Yiping, Hu, Jinxin, Zhu, Jun, Wu, Qiang, Cao, Tinghu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891168/ https://www.ncbi.nlm.nih.gov/pubmed/33596896 http://dx.doi.org/10.1186/s12894-021-00792-w

Ejemplares similares

CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
por: Chen, Xi, et al.
Publicado: (2022)

Survival outcomes in prostate cancer patients with a prior cancer
por: Zang, Yan, et al.
Publicado: (2021)

Erratum to survival outcomes in prostate cancer patients with a prior cancer
Publicado: (2021)

Exosomal prostate-specific G-protein-coupled receptor induces osteoblast activity to promote the osteoblastic metastasis of prostate cancer
por: Li, Yao, et al.
Publicado: (2020)

A Novel Androgen-Induced lncRNA FAM83H-AS1 Promotes Prostate Cancer Progression via the miR-15a/CCNE2 Axis
por: Liu, Bo, et al.
Publicado: (2021)

Survival outcomes in esophageal cancer patients with a prior cancer
por: Pan, Deqiang, et al.
Publicado: (2021)

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
por: Chen, Xi, et al.
Publicado: (2022)

Impact of prior cancer history on the survival of patients with larynx cancer
por: Zhu, Kaiquan, et al.
Publicado: (2020)

Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer
por: Rocque, Gabrielle B., et al.
Publicado: (2020)

Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score–Adjusted, Population-Based Study
por: Lin, Caijin, et al.
Publicado: (2020)

Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021)

Impact of prior cancer history on the overall survival of younger patients with lung cancer
por: Liu, Jiaqing, et al.
Publicado: (2020)

Impact of prior cancer history on survival of patients with hypopharyngeal cancer
por: Liang, Qi‐Wei, et al.
Publicado: (2022)

Effect of Prior Local Treatment and Prostate-Specific Antigen Kinetics during Androgen-Deprivation Therapy on the Survival of Castration-Resistant Prostate Cancer
por: Hah, Yoon Soo, et al.
Publicado: (2019)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

Safety and Survival Outcomes of (177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior (223)Ra treatment: The RALU Study
por: Rahbar, Kambiz, et al.
Publicado: (2023)

Genomic correlates of clinical outcome in advanced prostate cancer
por: Abida, Wassim, et al.
Publicado: (2019)

Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality
por: Mirabeau-Beale, Kristina, et al.
Publicado: (2014)

The impact of a prior malignancy on outcomes in gastric cancer patients
por: Bian, Xiaoyuan, et al.
Publicado: (2021)

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

Systematic Review and Meta-analysis of the Survival Outcomes of First-line Treatment Options in High-risk Prostate Cancer
por: Lei, Jun H., et al.
Publicado: (2015)

Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre
por: Daniel, C R, et al.
Publicado: (2016)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
por: Shore, Neal D., et al.
Publicado: (2021)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
por: Lin, Jian-Zhong, et al.
Publicado: (2017)

The effects of a prior malignancy on the survival of patients with ovarian cancer: a population-based study
por: Bian, Xiaoyuan, et al.
Publicado: (2020)

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study
por: Chen, Hao Xiang, et al.
Publicado: (2023)

Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives
por: Zheng, Guoqiao, et al.
Publicado: (2022)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer
por: Huynh, Linda My, et al.
Publicado: (2022)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
por: Sun, Xuqi, et al.
Publicado: (2021)

Survival in non-small cell lung cancer patients with versus without prior cancer
por: Sato, Akira, et al.
Publicado: (2023)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2023)

Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis
por: Marino, Natascia, et al.
Publicado: (2020)

Survival outcomes of low prostate-specific antigen levels and T stages in patients with high-grade prostate cancer: a population-matched study
por: Kang, Yongming, et al.
Publicado: (2020)

Survival Outcomes and Prognostic Analysis Following Greater Cytoreductive Radiotherapy in Patients With Metastatic Prostate Cancer
por: Zhang, Zitong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2n7a7o15p7pg16mq4linirbclb